Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors —data from a large national quality register
There are limited data regarding efficacy of abatacept treatment for rheumatoid arthritis (RA) outside clinical trials. Quality registers have been useful for observational studies on tumor necrosis factor inh...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Giovanni Cagnotto, Minna Willim, Jan- Åke Nilsson, Michele Compagno, Lennart T. H. Jacobsson, Saedis Saevarsdottir and Carl Turesson Tags: Research article Source Type: research
More News: Abatacept | Arthritis | Clinical Trials | Orencia | Rheumatoid Arthritis | Rheumatology | Study